Home Healthcare Biotechnology Biologics Contract Manufacturing Market

Biologics Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Monoclonal Antibodies, Recombinant Proteins, Vaccines, Cell & Gene Based Biologics, Antisense & Molecular Therapy), By Indication (Oncology, Autoimmune Diseases, Infectious Diseases, Cardiovascular Diseases, Metabolic Diseases, Neurology) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 12, 2026 | Author: Straits Research Team | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Biologics Contract Manufacturing Market, By Product 2025-2034 (USD MILLION/ Units)
    1. Monoclonal Antibodies
    2. Recombinant Proteins
    3. Vaccines
    4. Cell & Gene Based Biologics
    5. Antisense & Molecular Therapy
  2. Biologics Contract Manufacturing Market, By Indication 2025-2034 (USD MILLION/ Units)
    1. Oncology
    2. Autoimmune Diseases
    3. Infectious Diseases
    4. Cardiovascular Diseases
    5. Metabolic Diseases
    6. Neurology
  3. Regional Biologics Contract Manufacturing Market
    1. North America
      1. North America Biologics Contract Manufacturing Market By Product 2025-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
      2. North America Biologics Contract Manufacturing Market By Indication 2025-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Infectious Diseases
        4. Cardiovascular Diseases
        5. Metabolic Diseases
        6. Neurology
      3. U.S.
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      4. Canada
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
    2. Europe
      1. Europe Biologics Contract Manufacturing Market By Product 2025-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
      2. Europe Biologics Contract Manufacturing Market By Indication 2025-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Infectious Diseases
        4. Cardiovascular Diseases
        5. Metabolic Diseases
        6. Neurology
      3. U.K.
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      4. Germany
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      5. France
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      6. Spain
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      7. Italy
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      8. Russia
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      9. Nordic
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      10. Benelux
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      11. Rest of Europe
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
    3. APAC
      1. APAC Biologics Contract Manufacturing Market By Product 2025-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
      2. APAC Biologics Contract Manufacturing Market By Indication 2025-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Infectious Diseases
        4. Cardiovascular Diseases
        5. Metabolic Diseases
        6. Neurology
      3. China
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      4. Korea
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      5. Japan
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      6. India
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      7. Australia
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      8. Taiwan
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      9. South East Asia
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      10. Rest of Asia-Pacific
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
    4. Middle East and Africa
      1. Middle East and Africa Biologics Contract Manufacturing Market By Product 2025-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
      2. Middle East and Africa Biologics Contract Manufacturing Market By Indication 2025-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Infectious Diseases
        4. Cardiovascular Diseases
        5. Metabolic Diseases
        6. Neurology
      3. UAE
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      4. Turkey
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      5. Saudi Arabia
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      6. South Africa
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      7. Egypt
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      8. Nigeria
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      9. Rest of MEA
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
    5. LATAM
      1. LATAM Biologics Contract Manufacturing Market By Product 2025-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
      2. LATAM Biologics Contract Manufacturing Market By Indication 2025-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Infectious Diseases
        4. Cardiovascular Diseases
        5. Metabolic Diseases
        6. Neurology
      3. Brazil
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      4. Mexico
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      5. Argentina
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      6. Chile
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      7. Colombia
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
      8. Rest of LATAM
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Cell & Gene Based Biologics
        5. Antisense & Molecular Therapy
        6. Oncology
        7. Autoimmune Diseases
        8. Infectious Diseases
        9. Cardiovascular Diseases
        10. Metabolic Diseases
        11. Neurology
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.